Ingevity Corp

  • Earnings Score
  • Moat Score
  • Safety Score
  • Market Cap $1.42B
  • PE -3
  • Debt $1.47B
  • Cash $86.60M
  • EV $2.80B
  • FCF $51.00M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings-$430.30M
EBIT$369.00M
ROE-220%
ROA18%
FCF$51.00M
Equity$195.20M
Growth Stability-398%
PE-3.3
PEG5.4
PB7.28
P/FCF27.88
P/S1.01
Price/Cash0.06
Debt/Equity7.51
Debt/FCF28.75
Net Margins-31%
Gross Margins32%
Op. Margins26%
Earnings CAGR5%
Sales Growth YoY-20%
Sales Growth QoQ-21%
Sales CAGR8%
FCF CAGR4%
Equity CAGR11%
Earnings Stability0.14
Earnings Growth YoY-114%
Earnings Growth QoQ-115%
Earnings CAGR 5Y-1%
Sales CAGR 5Y7%
FCF CAGR 5Y-30%
Equity CAGR 5Y-13%
Earnings CAGR 3Y-1%
Sales CAGR 3Y-1%
FCF CAGR 3Y-42%
Equity CAGR 3Y-35%
Market Cap$1.42B
Revenue$1.41B
Assets$2.02B
Total Debt$1.47B
Cash$86.60M
Shares Outstanding36.31M
EV2.8B
Earnings Score8%
Moat Score33%
Safety Score25%
Final Score22%
Working Capital229.1M
Current Ratio1.87
Gross Profit$454.70M
Shares Growth 3y-2%
Equity Growth QoQ-9%
Equity Growth YoY-69%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through two segments, namely Performance Chemicals and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals which find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focusses on automotive carbon products used in automobiles. The Company sells its products worldwide, with special emphasis on North America.

SEC Filings

Direct access to Ingevity Corp (NGVT) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2024
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2022
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Ingevity Corp compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Ingevity Corp compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 5%
Stability 14%
loading chart...

Ingevity Corp Discounted Cash Flow

Fully customizable DCF calculator online for Ingevity Corp.

= $655M
012345678910TV
fcf$51M$53M$55M$57M$59M$61M$63M$66M$68M$70M$73M$730M
DCF$48M$45M$43M$40M$38M$36M$34M$32M$30M$28M$281M
Value$655M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024TTM
Net Margins8%4%13%15%14%15%8%13%-0%-31%-31%
ROA-20%22%20%19%17%17%17%15%18%18%
ROE-26%46%50%35%28%18%30%-1%-220%-220%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024TTM
Debt over FCF-7.013.824.877.964.936.878.6816.3428.7528.75
Debt over Equity0.173.711.672.272.412.081.932.122.477.517.51
Growth Stability---100%100%100%66%100%-3%-398%-398%

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201512/201612/201712/201812/201912/202012/202112/202212/202312/2024CAGR 5Y
Revenue YoY growth--5%7%17%14%-6%14%20%1%-17%7%
Earnings YoY growth--56%259%34%9%-1%-35%79%-103%8K%-1%
Equity YoY growth--74%106%22%57%21%5%4%-10%-69%-13%
FCF YoY growth--348%71%30%2%68%-30%-10%-44%-46%-30%